Hera-MI brings AI to improve breast cancer early detection to increase recovery rate and to optimize healthcare treatment for women. 

Breast Cancer is one of the leading cancer causes among women. However, when diagnosed early, patient can recover in almost 90% of cases. 

Hera-MI is developing a clinical decision support system based on machine learning and medical imaging processing that improve breast cancer early detection. The system enhance diagnosis quality and accuracy while reducing radiologists interpretation time. 

Moreover Hera-MI solution focuses on patient care improvement. With the more efficient breast cancer screening it allows women to be treated earlier and thus offers them higher chances for recovery. 


Hera-MI

SYLVIE DAVILA

This department focuses on innovation and the development of new products and technologies.

Research and Development

This department oversees the strategic direction and overall management of the organization.

Executive Leadership

This department focuses on defining product vision, strategy, and roadmap while ensuring successful product delivery and stakeholder alignment.

Hera-MI

Org chart

Teams

Research and Development

Executive Leadership

Product Management

Offices

Hera-MI

Org chart

Teams

Research and Development

Executive Leadership

Product Management

Offices

Related companies